In a stunning development, a former Chief Science Officer for the pharmaceutical giant Pfizer says "there is no science to suggest a second wave should happen." The "Big Pharma" insider asserts that false positive results from inherently unreliable COVID tests are being used to manufacture a "second wave" based on "new cases."
Dr. Mike Yeadon, a former Vice President and Chief Science Officer for Pfizer for 16 years, says that half or even "almost all" of tests for COVID are false positives. Dr. Yeadon also argues that the threshold for herd immunity may be much lower than previously thought, and may have been reached in many countries already.
Artikel gaat verder:
https://hubpages.com/poli(...)ses-Pandemic-is-Over
Net zo kut:quote:Op donderdag 22 oktober 2020 21:32 schreef OProg het volgende:
Het lijkt me best kut om False-Positive op de IC terecht te komen.
The growing evidence on lockdown deaths
That the lockdown had a terrible impact on the nation’s health — in ways other than just Covid-19 — is becoming clearer by the day. But just how bad was it?
According to a study by the London School of Hygiene and Tropical Medicine, delayed and cancelled breast cancer treatments will cause between 281 and 344 additional deaths. For colorectal cancer, there were an extra 1,445 to 1,563 deaths, lung cancer an additional 1,235 to 1372 deaths and 330 to 342 more oesophagal cancer deaths.
A University of Leeds study estimated that there have already been an extra 2,085 deaths from heart disease and stroke as a result of people not accessing timely medical help. A study by the University Hospital of Northern Tees reveals that the number of endoscopies — used to investigate and diagnose bowel cancer — fell to just 12 per cent of their normal level between 24 March and 31 May
The National Blood and Transplant Service looked at the period between 23 March and 10 May and found that, compared with the same period in 2019, the number of organ donors fell by 66 per cent and the number of transplants fell by 68 per cent. This year, 87 people died while waiting for an organ transplant, compared with 47 last year.
According to the ONS, an extra 25,472 people have died at home than would otherwise be expected from the average past five years — some of them, no doubt, would have died even if they had reached hospital, but not all. Meanwhile, the NSPCC has reported that calls to its helpline averaged 8,287 in May compared with 5,593 in early March, as children were shut away at home with their abusers.
These are just a few of the effects of lockdown, and of the poor messaging that led to many people failing to seek medical attention. These numbers will eventually have to be balanced against the lives potentially saved by the lockdown.
https://www.spectator.co.(...)e-on-lockdown-deaths
Je ziet wel steeds vaker hé. Mensen die in fatsoenlijke positie zaten, op oudere leeftijd toch nog al die aandacht missen.
In de zeven dagen voor het interview (5 tot 11 september) vielen er 77 doden in de UK. Toen leek het misschien alsof de pandemic over was. In de zeven dagen van 24 tot 30 oktober waren het er 1658...quote:Even more significantly, even if all positives were to be correct, Dr. Yeadon said that given the "shape" of all important indicators in a worldwide pandemic, such as hospitalizations, ICU utilization, and deaths, "the pandemic is fundamentally over."
Yeadon said in the interview:
"Were it not for the test data that you get from the TV all the time, you would rightly conclude that the pandemic was over, as nothing much has happened. Of course people go to the hospital, moving into the autumn flu season...but there is no science to suggest a second wave should happen."
In a paper published this month, which was co-authored by Yeadon and two of his colleagues, "How Likely is a Second Wave?", the scientists write:
"It has widely been observed that in all heavily infected countries in Europe and several of the US states likewise, that the shape of the daily deaths vs. time curves is similar to ours in the UK. Many of these curves are not just similar, but almost super imposable."
In the data for UK, Sweden, the US, and the world, it can be seen that in all cases, deaths were on the rise in March through mid or late April, then began tapering off in a smooth slope which flattened around the end of June and continues to today. The case rates however, based on testing, rise and swing upwards and downwards wildly.
This video provides one of the most erudite and informative looks at Covid-19 and the consequences of lockdowns. It was remarkable this week to watch as it appeared on YouTube and was forcibly taken down only 2 hours after posting. The copy below is hosted on LBRY, a blockchain video application. In a year of fantastic educational content, this is one of the best we’ve seen.
Consider the presenter’s bio:
Dr. Michael Yeadon is an Allergy & Respiratory Therapeutic Area expert with 23 years in the pharmaceutical industry. He trained as a biochemist and pharmacologist, obtaining his PhD from the University of Surrey (UK) in 1988.
Dr. Yeadon then worked at the Wellcome Research Labs with Salvador Moncada with a research focus on airway hyper-responsiveness and effects of pollutants including ozone and working in drug discovery of 5-LO, COX, PAF, NO and lung inflammation. With colleagues, he was the first to detect exhaled NO in animals and later to induce NOS in lung via allergic triggers.
Joining Pfizer in 1995, he was responsible for the growth and portfolio delivery of the Allergy & Respiratory pipeline within the company. He was responsible for target selection and the progress into humans of new molecules, leading teams of up to 200 staff across all disciplines and won an Achievement Award for productivity in 2008.
Under his leadership the research unit invented oral and inhaled NCEs which delivered multiple positive clinical proofs of concept in asthma, allergic rhinitis and COPD. He led productive collaborations such as with Rigel Pharmaceuticals (SYK inhibitors) and was involved in the licensing of Spiriva and acquisition of the Meridica (inhaler device) company.
Dr. Yeadon has published over 40 original research articles and now consults and partners with a number of biotechnology companies. Before working with Apellis, Dr. Yeadon was VP and Chief Scientific Officer (Allergy & Respiratory Research) with Pfizer.
Artikel gaat verder en de volledige video van 30 minuten is hier te zien:
https://www.aier.org/arti(...)former-vp-of-pfizer/